DK1150988T3 - Phosphoramidat og mono-, di- og triphosphorsyreestere af (1R,cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopenten-1-methanol som antivirale midler - Google Patents
Phosphoramidat og mono-, di- og triphosphorsyreestere af (1R,cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopenten-1-methanol som antivirale midlerInfo
- Publication number
- DK1150988T3 DK1150988T3 DK00905043T DK00905043T DK1150988T3 DK 1150988 T3 DK1150988 T3 DK 1150988T3 DK 00905043 T DK00905043 T DK 00905043T DK 00905043 T DK00905043 T DK 00905043T DK 1150988 T3 DK1150988 T3 DK 1150988T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclopenten
- purin
- antivirals
- phosphoramidate
- cis
- Prior art date
Links
- COZAZKCWQGBJDE-JGVFFNPUSA-N [(1r,4s)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]methanol Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@@H](CO)C=C1 COZAZKCWQGBJDE-JGVFFNPUSA-N 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
- 229940121357 antivirals Drugs 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9903090.0A GB9903090D0 (en) | 1999-02-12 | 1999-02-12 | Therapeutic compounds |
| US17020599P | 1999-12-10 | 1999-12-10 | |
| PCT/EP2000/001045 WO2000047591A1 (en) | 1999-02-12 | 2000-02-10 | Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1150988T3 true DK1150988T3 (da) | 2003-09-29 |
Family
ID=26315118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00905043T DK1150988T3 (da) | 1999-02-12 | 2000-02-10 | Phosphoramidat og mono-, di- og triphosphorsyreestere af (1R,cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopenten-1-methanol som antivirale midler |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7115590B1 (da) |
| EP (1) | EP1150988B1 (da) |
| JP (1) | JP2002536452A (da) |
| KR (1) | KR20010102082A (da) |
| CN (1) | CN1346360A (da) |
| AR (1) | AR031975A1 (da) |
| AT (1) | ATE241633T1 (da) |
| AU (1) | AU772478B2 (da) |
| BR (1) | BR0008135A (da) |
| CA (1) | CA2362662A1 (da) |
| CZ (1) | CZ20012908A3 (da) |
| DE (1) | DE60002986T2 (da) |
| DK (1) | DK1150988T3 (da) |
| DZ (1) | DZ3007A1 (da) |
| ES (1) | ES2200820T3 (da) |
| HK (1) | HK1039337B (da) |
| HU (1) | HUP0105476A3 (da) |
| IL (1) | IL144647A0 (da) |
| NO (1) | NO20013910L (da) |
| NZ (1) | NZ513450A (da) |
| PL (1) | PL204458B1 (da) |
| PT (1) | PT1150988E (da) |
| TR (1) | TR200102313T2 (da) |
| WO (1) | WO2000047591A1 (da) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20010915A1 (es) * | 1999-12-10 | 2001-09-29 | Glaxo Group Ltd | Analogos de (1s, cis)-4-(2-amino-9h-purin-9-il)-2-ciclopenten-1-metanol para uso en el tratamiento de infecciones virales |
| US20030045508A1 (en) * | 1999-12-10 | 2003-03-06 | Daluge Susan Mary | (1r,cis)-4-(4-amino-7h-pyrrolo'2,3-i(d) pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral |
| EA200601591A1 (ru) | 2000-05-26 | 2007-02-27 | Айденикс (Кайман) Лимитед | Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций |
| CN100402539C (zh) † | 2000-07-21 | 2008-07-16 | 吉里德科学公司 | 核苷酸膦酸酯类似物前药及其筛选和制备方法 |
| GB0129945D0 (en) * | 2001-12-13 | 2002-02-06 | Mrc Technology Ltd | Chemical compounds |
| GB0401088D0 (en) | 2004-01-19 | 2004-02-18 | Univ Cardiff | Phosphoramidate derivatives |
| WO2012154321A1 (en) | 2011-03-31 | 2012-11-15 | Idenix Pharmaceuticals, Inc. | Compounds and pharmaceutical compositions for the treatment of viral infections |
| AR088441A1 (es) | 2011-09-12 | 2014-06-11 | Idenix Pharmaceuticals Inc | Compuestos de carboniloximetilfosforamidato sustituido y composiciones farmaceuticas para el tratamiento de infecciones virales |
| US8507460B2 (en) | 2011-10-14 | 2013-08-13 | Idenix Pharmaceuticals, Inc. | Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections |
| EP2852605B1 (en) | 2012-05-22 | 2018-01-31 | Idenix Pharmaceuticals LLC | 3',5'-cyclic phosphate prodrugs for hcv infection |
| WO2013177219A1 (en) | 2012-05-22 | 2013-11-28 | Idenix Pharmaceuticals, Inc. | D-amino acid compounds for liver disease |
| EP2852604B1 (en) | 2012-05-22 | 2017-04-12 | Idenix Pharmaceuticals LLC | 3',5'-cyclic phosphoramidate prodrugs for hcv infection |
| SG11201407336PA (en) | 2012-05-25 | 2015-03-30 | Janssen Sciences Ireland Uc | Uracyl spirooxetane nucleosides |
| EP2900682A1 (en) | 2012-09-27 | 2015-08-05 | IDENIX Pharmaceuticals, Inc. | Esters and malonates of sate prodrugs |
| TR201809048T4 (tr) | 2012-10-08 | 2018-07-23 | Centre Nat Rech Scient | Hcv enfeksiyonu için 2'-kloro nükleosit analogları. |
| WO2014066239A1 (en) | 2012-10-22 | 2014-05-01 | Idenix Pharmaceuticals, Inc. | 2',4'-bridged nucleosides for hcv infection |
| EP2935304A1 (en) | 2012-12-19 | 2015-10-28 | IDENIX Pharmaceuticals, Inc. | 4'-fluoro nucleosides for the treatment of hcv |
| WO2014137926A1 (en) | 2013-03-04 | 2014-09-12 | Idenix Pharmaceuticals, Inc. | 3'-deoxy nucleosides for the treatment of hcv |
| WO2014137930A1 (en) | 2013-03-04 | 2014-09-12 | Idenix Pharmaceuticals, Inc. | Thiophosphate nucleosides for the treatment of hcv |
| EP2970357A1 (en) | 2013-03-13 | 2016-01-20 | IDENIX Pharmaceuticals, Inc. | Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv |
| WO2014165542A1 (en) | 2013-04-01 | 2014-10-09 | Idenix Pharmaceuticals, Inc. | 2',4'-fluoro nucleosides for the treatment of hcv |
| US10005779B2 (en) | 2013-06-05 | 2018-06-26 | Idenix Pharmaceuticals Llc | 1′,4′-thio nucleosides for the treatment of HCV |
| US20150037282A1 (en) | 2013-08-01 | 2015-02-05 | Idenix Pharmaceuticals, Inc. | D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease |
| WO2015161137A1 (en) | 2014-04-16 | 2015-10-22 | Idenix Pharmaceuticals, Inc. | 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv |
| GEP20217282B (en) | 2015-03-06 | 2021-08-10 | Atea Pharmaceuticals Inc | β-D-2'-DEOXY-2'α-FLUORO-2'-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT |
| US10711029B2 (en) | 2016-07-14 | 2020-07-14 | Atea Pharmaceuticals, Inc. | Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection |
| HRP20220278T1 (hr) | 2016-09-07 | 2022-05-13 | Atea Pharmaceuticals, Inc. | 2'-supstituirani-n6-supstituirani purinski nukleotidi za liječenje bolesti izazvanih rnk virusima |
| WO2021173713A1 (en) | 2020-02-27 | 2021-09-02 | Atea Pharmaceuticals, Inc. | Highly active compounds against covid-19 |
| US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244896A (en) * | 1990-09-14 | 1993-09-14 | Marion Merrell Dow Inc. | Carbocyclic adenosine analogs useful as immunosuppressants |
| GB9505025D0 (en) * | 1995-03-13 | 1995-05-03 | Medical Res Council | Chemical compounds |
| US6887707B2 (en) * | 1996-10-28 | 2005-05-03 | University Of Washington | Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
| GB9821058D0 (en) * | 1998-09-28 | 1998-11-18 | Univ Cardiff | Chemical compound |
| US20030045508A1 (en) * | 1999-12-10 | 2003-03-06 | Daluge Susan Mary | (1r,cis)-4-(4-amino-7h-pyrrolo'2,3-i(d) pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral |
| US20030096833A1 (en) * | 2001-08-31 | 2003-05-22 | Jagtap Prakash G. | Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
-
2000
- 2000-02-10 NZ NZ513450A patent/NZ513450A/xx unknown
- 2000-02-10 CZ CZ20012908A patent/CZ20012908A3/cs unknown
- 2000-02-10 ES ES00905043T patent/ES2200820T3/es not_active Expired - Lifetime
- 2000-02-10 PL PL350023A patent/PL204458B1/pl not_active IP Right Cessation
- 2000-02-10 IL IL14464700A patent/IL144647A0/xx unknown
- 2000-02-10 AT AT00905043T patent/ATE241633T1/de not_active IP Right Cessation
- 2000-02-10 AU AU26713/00A patent/AU772478B2/en not_active Ceased
- 2000-02-10 EP EP00905043A patent/EP1150988B1/en not_active Expired - Lifetime
- 2000-02-10 DE DE60002986T patent/DE60002986T2/de not_active Expired - Fee Related
- 2000-02-10 TR TR2001/02313T patent/TR200102313T2/xx unknown
- 2000-02-10 DK DK00905043T patent/DK1150988T3/da active
- 2000-02-10 US US09/913,226 patent/US7115590B1/en not_active Expired - Fee Related
- 2000-02-10 HU HU0105476A patent/HUP0105476A3/hu unknown
- 2000-02-10 JP JP2000598510A patent/JP2002536452A/ja active Pending
- 2000-02-10 PT PT00905043T patent/PT1150988E/pt unknown
- 2000-02-10 CA CA002362662A patent/CA2362662A1/en not_active Abandoned
- 2000-02-10 CN CN00806002A patent/CN1346360A/zh active Pending
- 2000-02-10 AR ARP000100596A patent/AR031975A1/es not_active Application Discontinuation
- 2000-02-10 KR KR1020017010198A patent/KR20010102082A/ko not_active Application Discontinuation
- 2000-02-10 WO PCT/EP2000/001045 patent/WO2000047591A1/en not_active Application Discontinuation
- 2000-02-10 BR BR0008135-3A patent/BR0008135A/pt not_active IP Right Cessation
- 2000-03-09 DZ DZ000019A patent/DZ3007A1/xx active
-
2001
- 2001-08-10 NO NO20013910A patent/NO20013910L/no not_active Application Discontinuation
-
2002
- 2002-02-05 HK HK02100897.2A patent/HK1039337B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0105476A3 (en) | 2002-08-28 |
| TR200102313T2 (tr) | 2002-03-21 |
| CA2362662A1 (en) | 2000-08-17 |
| AU2671300A (en) | 2000-08-29 |
| PT1150988E (pt) | 2003-10-31 |
| AU772478B2 (en) | 2004-04-29 |
| DZ3007A1 (fr) | 2003-03-27 |
| BR0008135A (pt) | 2002-02-19 |
| WO2000047591A1 (en) | 2000-08-17 |
| DE60002986D1 (en) | 2003-07-03 |
| KR20010102082A (ko) | 2001-11-15 |
| CN1346360A (zh) | 2002-04-24 |
| HUP0105476A2 (en) | 2002-06-29 |
| PL350023A1 (en) | 2002-10-21 |
| DE60002986T2 (de) | 2004-05-19 |
| CZ20012908A3 (cs) | 2002-10-16 |
| EP1150988A1 (en) | 2001-11-07 |
| HK1039337A1 (en) | 2002-04-19 |
| US7115590B1 (en) | 2006-10-03 |
| IL144647A0 (en) | 2002-05-23 |
| PL204458B1 (pl) | 2010-01-29 |
| HK1039337B (zh) | 2003-11-21 |
| EP1150988B1 (en) | 2003-05-28 |
| AR031975A1 (es) | 2003-10-22 |
| NZ513450A (en) | 2004-03-26 |
| ES2200820T3 (es) | 2004-03-16 |
| NO20013910L (no) | 2001-10-10 |
| NO20013910D0 (no) | 2001-08-10 |
| ATE241633T1 (de) | 2003-06-15 |
| JP2002536452A (ja) | 2002-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1150988T3 (da) | Phosphoramidat og mono-, di- og triphosphorsyreestere af (1R,cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopenten-1-methanol som antivirale midler | |
| EP1417556A4 (en) | SYNCHRONIZATION BETWEEN SEVERAL BROWSERS | |
| FI20001485A (fi) | Matkaviestimen ohjaama ajoitussynkronointi CDMA-tietoliikennejärjestelmässä | |
| DE69515884D1 (de) | Synchrones mehrpunkt-zu-punkt cdma-nachrichtenübertragungssystem | |
| NO984147D0 (no) | Sammensetninger som inneholder kopolymerer som tykningsmidler | |
| DE59913950D1 (de) | Binaurale synchronisation | |
| AU2001236746A1 (en) | Convection steamer | |
| AU2520501A (en) | Synchronization in packet-switched telecommunications system | |
| IS5869A (is) | Hraðlosandi tafla | |
| DK2301541T3 (da) | Antibiotiske sammensætninger til behandling af øjet | |
| DE60135183D1 (de) | Raummultiplex Übertragungsverfahren und System | |
| BR9710913A (pt) | Composition de vaccina malaria | |
| IT1297371B1 (it) | Espansore ortodontico | |
| DE60028701D1 (de) | Synchronisiereinrichtung | |
| DK0915076T3 (da) | Fremgangsmåde til fremstilling af trans-(R,R)-actinol | |
| DK1632490T3 (da) | Stereoselektiv fremgangsmåde til fremstillingen af nukleosidanaloger | |
| DK1105498T3 (da) | HIV vaccine | |
| ZA200106551B (en) | Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents. | |
| IT1316652B1 (it) | Procedimento di raddrizzatura per pezzi fragili | |
| SI1150988T1 (en) | Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents | |
| FI20012292A (fi) | Kasvisvalmiste | |
| DE50013578D1 (de) | Regalsystem | |
| FR2779769B1 (fr) | Groupe turbopompe | |
| NO20002213L (no) | Babesia vaksine | |
| DK1181271T3 (da) | Naphthalenurinstoffer som inhibitorer af glucoseoptagelse |